Get the Stockscreener App
0.4468
2.87%
-0.0132
After Hours:
.46
0.0132
+2.95%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.4468, with a volume of 903.65K.
It is down -2.87% in the last 24 hours and down -2.36% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.46
Open:
$0.46
24h Volume:
903.65K
Relative Volume:
0.37
Market Cap:
$30.38M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.6874
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-2.93%
1M Performance:
-2.36%
6M Performance:
-64.26%
1Y Performance:
-64.26%
1-Day Range:
$0.443
$0.46
1-Week Range:
$0.4411
$0.482
52-Week Range:
$0.30
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.4468 | 30.81M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant a turnaround storyMarket Sentiment Review & Precise Trade Entry Recommendations - khodrobank.com
Is Reviva Pharmaceuticals Holdings Inc. a strong growth stock2025 Pullback Review & Stock Timing and Entry Methods - khodrobank.com
How to use Fibonacci retracement on Reviva Pharmaceuticals Holdings Inc. Equity WarrantDip Buying & Stock Portfolio Risk Management - Newser
Visual trend scoring systems applied to Reviva Pharmaceuticals Holdings Inc.2025 Retail Activity & AI Driven Price Forecasts - Newser
Is Reviva Pharmaceuticals Holdings Inc. stock poised for growthQuarterly Profit Summary & Verified Entry Point Signals - Newser
Using Python tools to backtest Reviva Pharmaceuticals Holdings Inc. strategies2025 Market Sentiment & Expert Verified Movement Alerts - Newser
Sentiment analysis tools applied to Reviva Pharmaceuticals Holdings Inc.July 2025 Institutional & Growth Focused Entry Reports - Newser
Reviva Pharmaceuticals Holdings Inc. stock daily chart insightsDay Trade & Verified Entry Point Detection - Newser
Understanding Reviva Pharmaceuticals Holdings Inc.’s price movement2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
Tools to assess Reviva Pharmaceuticals Holdings Inc.’s risk profileEarnings Overview Report & Expert Verified Movement Alerts - Newser
Volume spikes in Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock – what they meanWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Combining price and volume data for Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Biggest Moves & Smart Money Movement Tracker - Newser
How to manage a losing position in Reviva Pharmaceuticals Holdings Inc.Weekly Trade Review & Capital Protection Trading Alerts - Newser
Advanced analytics toolkit walkthrough for Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - Newser
What MACD signals say about Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock momentum explainedJuly 2025 Reactions & Safe Capital Preservation Plans - Newser
Can technical indicators confirm Reviva Pharmaceuticals Holdings Inc. Equity Warrant’s reversalJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Using data models to predict Reviva Pharmaceuticals Holdings Inc. stock movementTrade Signal Summary & Free Fast Gain Swing Trade Alerts - Newser
Custom watchlist performance reports with Reviva Pharmaceuticals Holdings Inc.Quarterly Profit Report & Safe Capital Preservation Plans - Newser
Trend analysis for Reviva Pharmaceuticals Holdings Inc. Equity Warrant this weekDividend Hike & Intraday High Probability Alerts - Newser
Has Reviva Pharmaceuticals Holdings Inc. Equity Warrant formed a bullish divergenceWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant sustain earnings growthCEO Change & Detailed Earnings Play Strategies - khodrobank.com
Technical signs of recovery in Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Review & Long Hold Capital Preservation Plans - Newser
What’s next for Reviva Pharmaceuticals Holdings Inc. stock priceShare Buyback & Reliable Intraday Trade Plans - Newser
Can momentum traders help lift Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Retail Activity & High Return Stock Watch Alerts - Newser
Using AI based signals to follow Reviva Pharmaceuticals Holdings Inc.July 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Should you wait for a breakout in Reviva Pharmaceuticals Holdings Inc.2025 Market Sentiment & Risk Managed Trade Strategies - Newser
What Fibonacci levels say about Reviva Pharmaceuticals Holdings Inc. reboundMarket Rally & AI Driven Price Predictions - Newser
Published on: 2025-09-03 01:26:37 - khodrobank.com
Can Reviva Pharmaceuticals Holdings Inc. grow without external fundingEarnings Recap Summary & Fast Moving Market Watchlists - khodrobank.com
Custom strategy builders for tracking Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Gains Report & Reliable Intraday Trade Plans - Newser
What momentum shifts mean for Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant scale operations efficientlyJuly 2025 Trends & Verified Swing Trading Watchlists - khodrobank.com
How is Reviva Pharmaceuticals Holdings Inc. Equity Warrant managing supply chain issues2025 Short Interest & Entry and Exit Point Strategies - khodrobank.com
What is Reviva Pharmaceuticals Holdings Inc. s debt to equity ratioWeekly Investment Summary & Growth Focused Entry Point Reports - khodrobank.com
Visualizing Reviva Pharmaceuticals Holdings Inc. stock with heatmaps2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Automated trading signals detected on Reviva Pharmaceuticals Holdings Inc.July 2025 Market Mood & Community Consensus Stock Picks - Newser
Real time scanner hits for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explained2025 Technical Patterns & Consistent Profit Trade Alerts - Newser
Published on: 2025-09-02 01:44:24 - Newser
Leading vs lagging indicators on Reviva Pharmaceuticals Holdings Inc. performance2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant hit a new high this monthPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Should I invest in Reviva Pharmaceuticals Holdings Inc. before earningsWeekly Earnings Recap & AI Enhanced Market Trend Forecasts - khodrobank.com
Live market analysis of Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Movers & Low Drawdown Momentum Ideas - Newser
What is the PEG ratio of Reviva Pharmaceuticals Holdings Inc.Weekly Earnings Recap & Growth Focused Entry Point Reports - خودرو بانک
Reviva Pharmaceuticals Holdings Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock a value trap2025 Volatility Report & Low Risk Profit Maximizing Plans - khodrobank.com
How to monitor Reviva Pharmaceuticals Holdings Inc. with trend dashboardsWeekly Market Report & AI Optimized Trade Strategies - Newser
Is This the Dip to Buy in Reviva Pharmaceuticals Holdings Inc. Equity Warrant getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant maintain its current growth rateCPI Data & Risk Controlled Stock Pick Alerts - khodrobank.com
Real time social sentiment graph for Reviva Pharmaceuticals Holdings Inc.July 2025 Final Week & Pattern Based Trade Signal System - Newser
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):